(Q45865340)

17 December 2017

title

Newcastle disease virus selectively kills human tumor cells (English)

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

16 October 2022

1 reference

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

16 October 2022

4

M. E. Peeples

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

author name string

K. W. Reichard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

R. M. Lorence

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

C. J. Cascino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

R. J. Walter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

M. B. Fernando

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

H. M. Reyes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

J. A. Greager

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1619912

16 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1619912

16 October 2022

publication date

1 May 1992

1 reference

17 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:002248049290310V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

https://api.elsevier.com/content/article/PII:002248049290310V?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Journal of Surgical Research

16 October 2022

published in

1 reference

17 December 2017

volume

52

1 reference

17 December 2017

page(s)

448-453

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

VIRUSES IN THE TREATMENT OF CANCER

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Effects of viruses on tumors

16 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Present status of oncolytic virus studies

16 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Possible effect of measles on leukaemia

16 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

16 October 2022

Measles and leukaemia

7

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Regression of Burkitt's lymphoma in association with measles infection.

16 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Viruses in the treatment of cancer

16 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Treatment of human cancer with mumps virus

16 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

16 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Viral oncolysate in the management of malignant melanoma.I. Preparation of the oncolysate and measurement of immunologic responses

16 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Viral oncolysate in the management of malignant melanoma. II. Clinical studies

16 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

16 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Strain variation and nuclear association of Newcastle disease virus matrix protein

16 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

16 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

Factors Influencing the Interferon Response

16 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90310-V

16 October 2022

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017